Back
Clinical Significance of Plasma Levels of Soluble CD40 in Patients with Chronic Lymphocytic Leukemia
Barry D. Hock, Liam J. Fernyhough, Sheryl M. Gough, Judith L. McKenzie
Open J. Blood Dis. Vol.3 No.1, March 28, 2013  DOI: 10.4236/ojbd.2013.31001
       (PDF  261K)     HTML      XML
Correlates of Age at Initial Diagnosis of Chronic Lymphocytic Leukemia: Exercise, ASA & Emotional Distress
Mark W. Ketterer, Emily A. Ketterer, Bernd Barthel, Amr Hanbali, Phillip Kuriakose, Yue Guo, Walter Knysz
Open J. Med. Psychol. Vol.1 No.2, April 16, 2012  DOI: 10.4236/ojmp.2012.12002
       (PDF  69K)     HTML      XML
The Challenges of Diagnosing Disseminated Lyme Disease in a Patient with CLL
Solaiman Futuri, Afshan Malik, Dana Shani
Open J. Blood Dis. Vol.2 No.1, March 01, 2012  DOI: 10.4236/ojbd.2012.21003
       (PDF  50K)     HTML      XML
The Effect of Curcumin (as Meriva) on Absolute Lymphocyte Count (ALC), NK Cells and T Cell Populations in Patients with Stage 0/1 Chronic Lymphocytic Leukemia
Terry Golombick, Terrence H. Diamond, Arumugam Manoharan, Rajeev Ramakrishna
J. Cancer Ther. Vol.6 No.7, July 13, 2015  DOI: 10.4236/jct.2015.67061
       (PDF  244K)     HTML      XML
The Unmet Need in Chronic Lymphocytic Leukemia: Impact of Comorbidity Burden on Treatment Patterns and Outcomes in Elderly Patients
Sacha Satram-Hoang, Carolina Reyes, Khang Q. Hoang, Faiyaz Momin, Sandra Skettino
J. Cancer Ther. Vol.4 No.8, October 25, 2013  DOI: 10.4236/jct.2013.48156
       (PDF  813K)     HTML     
 
 
Top